Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/07/23 04:20:00 on US and Canada Markets.
ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that multiple oral and poster present...
Record Quarterly Net Revenue of $50 Million for Q3 2023, Up 48% from Q3 2022 Raises Full-Year 2023 Net Revenue Guidance from $185 to $195 Million to $194 to $198 Million Operating Use of Cash in Q3 of $0.9 Million, Demonstrating Continued Progress Towards Achieving Profitability ...
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
BROOKFIELD News, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) and its listed affiliate Brookfield Business Partners (NYSE: BBU; TSX: BBU.UN) today announced the completion of the sale of Westinghouse Electric Company (“Westinghouse” or “...
BROOKFIELD News, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) and its listed affiliate Brookfield Business Partners (NYSE: BBU; TSX: BBU.UN) today announced the completion of the sale of Westinghouse Electric Company (“Westinghouse” or “...
BROOKFIELD News, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) and its listed affiliate Brookfield Business Partners (NYSE: BBU; TSX: BBU.UN) today announced the completion of the sale of Westinghouse Electric Company (“Westinghouse” or “...
sBLA based on Phase 4 study which assessed pharmacokinetic similarity between two treatment groups: multi-switching group alternating between Humira and high-concentration HADLIMA vs. Humira-continued group Filing acceptance reinforces Samsung Bioepis and Organon’s commitment to pr...
Estimated combined risk-based capital ("RBC") ratio between 400% and 420%; holding company liquid assets of $0.9 billion Repurchased approximately $216 million of its common stock year-to-date through November 3, 2023 Third quarter year-to-date total annuity sales decr...
FARGO, N.D., Nov. 07, 2023 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (NASDAQ: NODK) announced today results for the quarter ended September 30, 2023. Summary of Third Quarter 2023 Results (All comparisons vs. the third quarter of 2022, unless noted otherwise) Direct written prem...
RAMACO RESOURCES REPORTS THIRD QUARTER 2023 RESULTS PR Newswire LEXINGTON, Ky. , Nov. 7, 2023 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company"), a leading operator and developer of high-quality, low-cost metallurgical coal, t...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
8.86%Change Percent:
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
iovance.com Website: